-
Hedge Funds Skim the Bottom in Weightloss Dogs (VVUS) (OREX) (ARNA)
-
Buy This Dip in Orexigen (OREX), RBC Capital Says
-
Orexigen (OREX) is Obesity's Comeback Kid, RBC Capital Says; PT to $14
-
Streetinsider.com's Hot Lunchtime Reads 3/6: (OREX) (FB) (TSLA) (AXAS)
-
RBC Capital Sees Less Than 10% Chance Orexigen's (OREX) Contrave is Pulled; Buy on Weakness
-
RBC Capital Starts Orexigen Therapeutics (OREX) at Outperform
-
Pre-Open Stock Movers 1/10: (ICPT) (SWS) (HLF) Higher; (YRCW) (FIVE) (AA) Lower (more...)
-
Pre-Open Movers 10/22: (PRGX) (ACOM) (BTU) Higher; (OSG) (NXY) (CAT) Lower (more...)
-
Notable Analyst Rating Changes 09/21: (OREX) (TOT) (ADSK) Upgraded; (BSBR) (CAB) (JEF) Downgraded
-
Notable Analyst Rating Changes 4/21: (OREX) (SLW) (SCHW) Upgraded; (WFC) (SINA) (TIVO) Downgraded
-
Morning Movers 12/02: WBD, KKD, OREX, MCOX, RNN, INAP, PSS, MOV Higher; ARO, INSM, KR, JAS Lower
-
Notable Analyst Rating Changes 07/16: GS, JPM, ARNA, ADM Upgraded; VVUS, BP, RBA, OREX Downgraded

